论文部分内容阅读
Janssen 公司将在6月1日在英国上市其新抗精神病药瑞司哌酮(risperidone,Risperdal)这是在加拿大之后的第二个市场,加拿大约在两周前上市。本品也已在墨西哥批准。将和 Organon 在英国共同推广。
Janssen will be listing its new antipsychotic risperidone (Risperdal) on June 1 in the UK, the second after Canada, with Canada about two weeks ago. This product has also been approved in Mexico. Organon will be jointly promoted in the UK.